发明名称 |
EFFICACIOUS TREATMENT OF NSCLC AND PREDICTIVE CLINICAL MARKER OF THE RESPONSIVENESS OF A TUMOUR TO A TREATMENT. |
摘要 |
The present invention relates to a beneficial treatment of tumours in patients suffering from NSCLC, and to a clinical marker useful as predictive variable of the responsiveness of tumours in patients suffering from NSCLC. The present invention further relates to a method for selecting patients likely to respond to a given therapy, wherein said method optionally comprises the use of a specific clinical marker. The present invention further relates to a method for delaying disease progression and/or prolonging patient survival of NSCLC patients, wherein said method comprises the use of a specific clinical marker. |
申请公布号 |
MX2015015525(A) |
申请公布日期 |
2016.02.05 |
申请号 |
MX20150015525 |
申请日期 |
2014.05.08 |
申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
ROLF KAISER;BIRGIT GASCHLER-MARKEFSKI |
分类号 |
A61K31/337;A61K31/496;A61K31/519;A61K45/06;A61P35/00 |
主分类号 |
A61K31/337 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|